Quick filters:
Open Data
Open Code
Pre-registered
Funding Declared
COI Declared
Open Access
Clear Filters
Increased MCL1 dependency leads to new applications of BH3-mimetics in drug-resistant neuroblastoma.
Jacob M; Wiedemann S; Brücher D; Pieper NM; Birkhold M; Särchen V; Jeroch J; Demes MC; Gretser S; Braun Y; Gradhand E; Rothweiler F; Michaelis M; Cinatl J; Vogler M.
Br J Cancer
(Unknown)
Published: 2023
Ex vivo drug sensitivity screening predicts response to temozolomide in glioblastoma patients and identifies candidate …
Ntafoulis I; Kleijn A; Ju J; Jimenez-Cowell K; Fabro F; Klein M; Chi Yen RT; Balvers RK; Li Y; Stubbs AP; Kers TV; Kros JM; Lawler SE; Beerepoot LV; Kremer A; Idbaih A; Verreault M; Byrne AT; O'Farrell AC; Connor K; Biswas A; Salvucci M; Prehn JHM; Lambrechts D; Dilcan G; Lodi F; Arijs I; van den Bent MJ; Dirven CMF; Leenstra S; GLIOTRAIN consortium; Lamfers MLM.
Br J Cancer
(Unknown)
Published: 2023
Dissecting the pathogenic effects of smoking and its hallmarks in blood DNA methylation on colorectal cancer risk.
Zhou X; Xiao Q; Jiang F; Sun J; Wang L; Yu L; Zhou Y; Zhao J; Zhang H; Yuan S; Timofeeva M; Spiliopoulou A; Mesa-Eguiagaray I; Farrington SM; Law PJ; Houlston RS; Ding K; Dunlop MG; Theodoratou E; Li X.
Br J Cancer
(Unknown)
Published: 2023
A Phase Ib/II study of IGF-neutralising antibody xentuzumab with enzalutamide in metastatic castration-resistant prosta…
Macaulay VM; Lord S; Hussain S; Maroto JP; Jones RH; Climent MÁ; Cook N; Lin CC; Wang SS; Bianchini D; Bailey M; Schlieker L; Bogenrieder T; de Bono J.
Br J Cancer
(Unknown)
Published: 2023
A Phase 1/2A trial of idroxioleic acid: first-in-class sphingolipid regulator and glioma cell autophagy inducer with an…
Lopez J; Lai-Kwon J; Molife R; Welsh L; Tunariu N; Roda D; Fernández-García P; Lladó V; McNicholl AG; Rosselló CA; Taylor RJ; Azaro A; Rodón J; Sludden J; Veal GJ; Plummer R; Urruticoechea A; Lahuerta A; Mujika K; Escribá PV.
Br J Cancer
(Unknown)
Published: 2023
Pamiparib in combination with tislelizumab in patients with advanced solid tumours: results from the dose-expansion sta…
Friedlander M; Mileshkin L; Lombard J; Frentzas S; Gao B; Wilson M; Meniawy T; Baron-Hay S; Briscoe K; McCarthy N; Fountzilas C; Cervantes A; Ge R; Wu J; Spira A.
Br J Cancer
(Unknown)
Published: 2023
MiR-662 is associated with metastatic relapse in early-stage breast cancer and promotes metastasis by stimulating cance…
Puppo M; Valluru MK; Croset M; Ceresa D; Iuliani M; Khan A; Wicinski J; Charafe-Jauffret E; Ginestier C; Pantano F; Ottewell PD; Clézardin P.
Br J Cancer
(Unknown)
Published: 2023